AX9 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Akebia Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.07 EUR -14.64% Market Closed

Market Cap: €356.3m

A	Akebia Therapeutics Inc SWB:AX9	US
I	ITV PLC DUS:IJ7	UK
G	Gilead Sciences Inc MIL:GILD	US
	MakeMyTrip Ltd NASDAQ:MMYT	IN
D	Dai Nippon Printing Co Ltd XBER:DNP	JP
V	Vector Group Ltd XBER:VGR	US
A	American Tower Corp F:A0T	US
T	TC Energy Corp NYSE:TRP	CA
C	Credit Suisse Group AG BMV:CSN	CH
C	Coherus BioSciences Inc F:8C5	US
F	Fomento de Construcciones y Contratas SA SWB:FCC	ES
G	Getlink SE OTC:GRPTY	FR

Profitability Summary

Akebia Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

79%

Strong 3Y Average Gross Margin

83%

Declining Gross Margin

85% > 79%

Low Operating Margin

Negative 3Y Average Operating Margin

-14%

Operating Margin is Increasing

-13% > 2%

Negative Net Margin

-9%

Negative 3Y Average Net Margin

-24%

Net Margin is Increasing

-23% > -9%

Exceptional Free Cash Flow Margin

22%

Negative 3Y Average Free Cash Flow Margin

-9%

Free Cash Flow Margin is Increasing

-26% > 22%

Negative ROE

-79%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-11%

ROIC is Increasing

-12% > 3%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.